Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter
- PMID: 39150065
- PMCID: PMC11393494
- DOI: 10.1093/europace/euae220
Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter
Abstract
Aims: Pulsed-field ablation (PFA) is a novel, myocardial-selective, non-thermal ablation modality used to target cardiac arrhythmias. Although prompt electrogram (EGM) signal disappearance is observed immediately after PFA application in the pulmonary veins, whether this finding results in adequate transmural lesions is unknown. The aim of this study is to check whether application repetition and catheter-tissue contact impact lesion formation during PFA.
Methods and results: A circular loop PFA catheter was used to deliver repeated energy applications with various levels of contact force. A benchtop vegetal potato model and a beating heart ventricular myocardial model were utilized to evaluate the impact of application repetition, contact force, and catheter repositioning on contiguity and lesion depth. Lesion development occurred over 18 h in the vegetal model and over 6 h in the porcine model. Lesion formation was found to be dependent on application repetition and contact. In porcine ventricles, single and multiple stacked applications led to a lesion depth of 3.5 ± 0.7 and 4.4 ± 1.3 mm, respectively (P = 0.002). Furthermore, the greater the catheter-tissue contact, the more contiguous and deeper the lesions in the vegetal model (1.0 ± 0.9 mm with no contact vs. 5.4 ± 1.4 mm with 30 g of force; P = 0.0001).
Conclusion: Pulsed-field ablation delivered via a circular catheter showed that both repetition and catheter contact led independently to deeper lesion formation. These findings indicate that endpoints for effective PFA are related more to PFA biophysics than to mere EGM attenuation.
Keywords: Catheter ablation; Irreversible electroporation; Pre-clinical model; Pulmonary vein isolation; Pulsed-field ablation.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: L.D.B. is a consultant for Stereotaxis, Biosense Webster, Boston Scientific, Abbott Medical, I-Rhythm, Siemens Medtronic, AtriCure, Biotronik, and Zoll. T.G., E.B., and V.G. are employees of Biosense Webster, Inc., a Johnson & Johnson company. All remaining authors have declared no conflicts of interest.
Figures
References
-
- Hsu JC, Gibson D, Banker R, Doshi SK, Gidney B, Gomez T et al. In vivo porcine characterization of atrial lesion safety and efficacy utilizing a circular pulsed-field ablation catheter including assessment of collateral damage to adjacent tissue in supratherapeutic ablation applications. J Cardiovasc Electrophysiol 2022;33:1480–8. - PMC - PubMed
